“…Putative benefits of hyperbaric oxygen therapy include the provision of adequate oxygenation for optimal neutrophil phagocytic function, the inhibition of anaerobic growth by tissue hyperoxygenation, increased fibroblast proliferation and angiogenesis, reduction of oedema by vasoconstriction, increased intracellular transport of antibiotics and increased generation of oxygen free‐radicals. Although its role in Fournier’s gangrene is supported by several small, retrospective studies [ 66, 67], hyperbaric oxygen therapy should not delay definitive surgical treatment. It is probably best reserved for patients who remain toxic despite maximal debridement and those with clinical or microbiological evidence of anaerobic infection [ 10], particularly in view of the limited availability of hyperbaric chambers.…”